Bortezomib
NDC 0409-1700, Bortezomib, injection, powder, lyophilized, for solution, from Hospira, Inc..
- Product NDC
- 0409-1700
- Status
- Listed
- Labeler
- Hospira, Inc.
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208460
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0409-1700 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BORTEZOMIB3.5 mg/1
Pharmacologic classes
Proteasome Inhibitor [EPC]; Proteasome Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0409-1700-01 | 00409170001 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-1700-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/41e3de39-8278-4a75-badf-601e4602080dMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0409-1700
Use it
Look up 0409-1700 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0409-1700 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0409-1700. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.